As of Aug 31
| -0.03 / -0.81%|
The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +173.22% increase from the last price of 3.66.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.